| Literature DB >> 33607080 |
Joseph F Welch1, Raphael R Perim2, Patrick J Argento3, Tommy W Sutor2, Alicia K Vose2, Jayakrishnan Nair2, Gordon S Mitchell2, Emily J Fox4.
Abstract
Acute intermittent hypoxia (AIH) is a strategy to improve motor output in humans with neuromotor impairment. A single AIH session increases the amplitude of motor evoked potentials (MEP) in a finger muscle (first dorsal interosseous), demonstrating enhanced corticospinal neurotransmission. Since AIH elicits phrenic/diaphragm long-term facilitation (LTF) in rodent models, we tested the hypothesis that AIH augments diaphragm MEPs in humans. Eleven healthy adults (7 males, age = 29 ± 6 years) were tested. Transcranial and cervical magnetic stimulation were used to induce diaphragm MEPs and compound muscle action potentials (CMAP) recorded by surface EMG, respectively. Stimulus-response curves were generated prior to and 30-60 min after AIH. Diaphragm LTF was assessed by measurement of integrated EMG burst amplitude and frequency during eupnoeic breathing before and after AIH. Following baseline measurements, AIH was delivered from an oxygen generator connected to a facemask under poikilocapnic conditions (15 one minute episodes of 9% inspired oxygen with one minute room air intervals). There were no detectable changes in MEP (-1.5 ± 12.1%, p = 0.96) or CMAP (+0.1 ± 7.8%, p = 0.97) amplitudes across the stimulus-response curve. At stimulation intensities approximating 50% of the difference between minimum and maximum baseline amplitudes, MEP and CMAP amplitudes were also unchanged (p > 0.05). Further, no AIH effect was observed on diaphragm EMG activity during eupnoea post-AIH (p > 0.05). We conclude that unlike hand muscles, poikilocapnic AIH does not enhance diaphragm MEPs or produce diaphragm LTF in healthy humans.Entities:
Keywords: Acute intermittent hypoxia; Cervical magnetic stimulation; Diaphragm; Electromyography; Neuroplasticity; Phrenic; Transcranial magnetic stimulation
Mesh:
Year: 2021 PMID: 33607080 PMCID: PMC8678369 DOI: 10.1016/j.expneurol.2021.113651
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330